Literature DB >> 7720762

Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men.

H H Mundal1, P Hjemdahl, K Gjesdal.   

Abstract

Twenty non-smoking middle-aged men with mild untreated essential hypertension were compared to age-matched controls (n = 22) in a double-blind placebo controlled study. Plasma and urinary concentrations of the platelet-specific protein beta-thromboglobulin (beta-TG), platelet count and mean platelet volume were measured before and after chewing 2 mg nicotine gum. The mean plasma nicotine concentration increased to 4.3 ng/ml in the hypertensive group and to 3.9 ng/ml in the normotensive group after 30 minutes of chewing the nicotine gum. Blood pressure and heart rate increased significantly, but there was no difference between the groups. Venous plasma catecholamine concentrations were unchanged. beta-TG concentrations in plasma and urine were similar in the two groups, and plasma beta-TG levels did not change after nicotine gum in either group. Urinary high molecular weight beta-TG decreased after nicotine compared to placebo. Platelet count and volume increased significantly in the hypertensive group, but not in the normotensive group. The response in platelet count was significantly higher in the hypertensive group. Thus, small amounts of nicotine increase platelet counts more in hypertensive than in normotensive non-smoking men, without inducing the platelet release reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720762     DOI: 10.1007/bf00196854

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

1.  A modified procedure for the determination of nicotine in blood.

Authors:  S E Falkman; I E Burrows; R A Lundgren; B F Page
Journal:  Analyst       Date:  1975-02       Impact factor: 4.616

Review 2.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

3.  Circulatory effects of nicotine aerosol inhalations and cigarette smoking in man.

Authors:  A Herxheimer
Journal:  Lancet       Date:  1967-10-07       Impact factor: 79.321

4.  Influence of platelet size on outcome after myocardial infarction.

Authors:  J F Martin; P M Bath; M L Burr
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

5.  Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study.

Authors:  C Garland; E Barrett-Connor; L Suarez; M H Criqui; D L Wingard
Journal:  Am J Epidemiol       Date:  1985-05       Impact factor: 4.897

6.  Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume.

Authors:  S Karpatkin
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

7.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.

Authors:  P E Cryer; M W Haymond; J V Santiago; S D Shah
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

8.  Nicotine induced haemodynamic changes during cigarette smoking and nicotine gum chewing: a placebo controlled study in young healthy volunteers.

Authors:  H Bounameaux; M Griessen; P Benedet; B Krahenbuhl; A Deom
Journal:  Cardiovasc Res       Date:  1988-02       Impact factor: 10.787

9.  Cardiovascular effect of nicotine chewing gum in healthy non-smokers.

Authors:  G Nyberg; V Panfilov; R Sivertsson; L Wilhelmsen
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

10.  Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.

Authors:  H H Mundal; G Nordby; K Lande; K Gjesdal; S E Kjeldsen; I Os
Journal:  Scand J Clin Lab Invest       Date:  1993-10       Impact factor: 1.713

View more
  6 in total

Review 1.  Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Authors:  Abhishek Sharma; Saurabh Thakar; Carl J Lavie; Jalaj Garg; Parasuram Krishnamoorthy; Ondrej Sochor; Armin Arbab-Zadeh; Edgar Lichstein
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

2.  Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension.

Authors:  E Sage Colombo; Joshua Davis; Mehran Makvandi; Mario Aragon; Selita N Lucas; Michael L Paffett; Matthew J Campen
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

3.  Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage.

Authors:  David B Seder; J Michael Schmidt; Neeraj Badjatia; Luis Fernandez; Fred Rincon; Jan Claassen; Errol Gordon; Emmanuel Carrera; Pedro Kurtz; Kiwon Lee; E Sander Connolly; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 4.  Nicotine: A Double-Edged Sword in Atherosclerotic Disease.

Authors:  Chun-Chieh Liu; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

Review 5.  Cardiovascular effects of pharmacologic therapies for smoking cessation.

Authors:  Diana M Sobieraj; William B White; William L Baker
Journal:  J Am Soc Hypertens       Date:  2012-12-21

6.  Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice.

Authors:  Ying Wang; Jian Wang; Rong Yang; Piwen Wang; Rene Porche; Samuel Kim; Kabirullah Lutfy; Limei Liu; Theodore C Friedman; Meisheng Jiang; Yanjun Liu
Journal:  Hypertension       Date:  2021-04-05       Impact factor: 9.897

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.